NC
EW icon

North Capital’s Edwards Lifesciences EW Stock Holding History

North Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$478K Buy
5,286
+21
+0.4% +$1.76K 0.36% 42
2026
Q1 		$422K Hold
5,265
– – 0.36% 42
2025
Q4 		$449K Sell
5,265
-1
-0% -$82 0.39% 38
2025
Q3 		$410K Buy
5,266
+22
+0.4% +$1.72K 0.32% 42
2025
Q2 		$410K Hold
5,244
– – 0.35% 37
2025
Q1 		$380K Buy
+5,244
New +$375K 0.36% 39

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

North Capital's EW Position: Q2 2026 in Review

North Capital increased its Edwards Lifesciences (EW) stake by 0.4% in Q2 2026, buying an estimated $1.76K and bringing the position to 5,286 shares worth $478K. The position accounts for 0.36% of the portfolio, ranked #42.

North Capital first reported a position in EW in Q1 2025 and has held it in 6 quarters since. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • North Capital held 5,286 shares of Edwards Lifesciences worth $478K as of Q2 2026.
  • North Capital bought 21 Edwards Lifesciences shares in Q2 2026, an estimated $1.76K.
  • Edwards Lifesciences made up 0.36% of North Capital's portfolio in Q2 2026, its #42 holding.
  • North Capital first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 6 quarters since.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on North Capital's 13F filing for Q2 2026, filed 14 Jul 2026.